Drug "Ursofalk" for newborn and adult patients

Diseases of newborn children are quite diverse. Some of them are congenital, some can be acquired. The nature of a number of pathologies has not yet been studied thoroughly. One of these diseases is jaundice of newborns. A forum on the health of infants or a site with information of a medical nature will not be able to provide the necessary assistance to parents who have encountered such a problem. In any case, a doctor's consultation is necessary. The doctor can recommend this or that hepatoprotective preparation if necessary. One of the popular means is Ursofalk. For newborns, a suspended form of the drug is produced.

Description

Hepatoprotective drug has choleretic effect. The agent reduces in the liver the synthesis of cholesterol, its absorption in the intestinal cavity and concentration, increasing its solubility in the system. The drug stimulates the secretion and secretion of bile, reduces its lithogenicity, increases the content of acids in it. The agent enhances pancreatic and gastric secretion, lipase activity, and also has a hypoglycemic effect. The drug promotes complete or partial dissolution of cholesterol stones. The drug also has an immunomodulatory effect, affecting the reactions in the liver. Thus, the agent reduces the expression of a number of antigens on the membrane of individual cells.

Indications

Drug "Ursofalk" for newborn and adult patients is prescribed only on the recommendation of a doctor. The drug is indicated for biliary reflux gastritis, primary biliary cirrhosis in the absence of signs of decompensation (as symptomatic therapy). The drug is prescribed for the dissolution of gallstones (cholesterol) in the gallbladder.

Contraindications. Side effects

Ursofalk for newborn and adult patients is not prescribed for hypersensitivity to components, dysfunctional gallbladder, expressed disorders of kidneys, liver. Contraindications include cirrhosis in the stage of decompensation. The drug is not recommended for X-ray positive (with high calcium content) gallstones, inflammation of the gallbladder in the acute stage. Against the background of the use of possible dyspeptic disorders, vomiting, allergies, nausea. In the treatment of biliary primary cirrhosis, transient decompensation may occur. As a rule, it passes after the withdrawal of the drug.

Mode of application

The dosage and the scheme of the drug "Ursofalk" for the newborn is prescribed by the doctor. Medication is taken orally. Tablets are not chewed. In accordance with the patient's condition and the nature of the pathology, an exact treatment regimen is established. For example, in liver pathologies, usually 10 mg per kilogram is prescribed twice or thrice during the day. With cholatease it is recommended to take the drug at the indicated dosage once a day. Duration of the drug can be from ten or fourteen days to six months. If necessary, the drug is prescribed for two years.